PTC Therapeutics Announces Initiation of Phase 2/3 Clinical Tr...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
SOUTH PLAINFIELD, N.J., Nov. 16, 2020 /PRNewswire-AsiaNet/ -- -- Oral treatment with novel dual-mechanism of action has the potential to address the two critical elements of COVID-19: viral replication and uncontrolled inflammatory response ---- Randomized, double-blind, placebo-controlled, Phase 2/3 cli...
Authors: LATEST ASIANET NEWS RELEASES